Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis
WL Beatty, RP Morrison, GI Byrne - Microbiological reviews, 1994 - Am Soc Microbiol
Chlamydiae are medically important bacteria responsible for a wide range of human
infections and diseases. Repeated episodes of infection promote chronic inflammation …
infections and diseases. Repeated episodes of infection promote chronic inflammation …
Diagnosis and assessment of trachoma
AW Solomon, RW Peeling, A Foster… - Clinical microbiology …, 2004 - Am Soc Microbiol
Trachoma is caused by Chlamydia trachomatis. Clinical grading with the WHO simplified
system can be highly repeatable provided graders are adequately trained and standardized …
system can be highly repeatable provided graders are adequately trained and standardized …
A critical review of the SAFE strategy for the prevention of blinding trachoma
Trachoma is an ocular disease caused by repeated infection with Chlamydia trachomatis. It
is the leading cause of infectious blindness globally, responsible for 5· 9 million cases of …
is the leading cause of infectious blindness globally, responsible for 5· 9 million cases of …
Global elimination of trachoma: how frequently should we administer mass chemotherapy?
Abstract The World Health Organization has recommended repeat mass drug administration
as part of their global initiative to eliminate blinding trachoma by the year 2020. The efficacy …
as part of their global initiative to eliminate blinding trachoma by the year 2020. The efficacy …
Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay
Detection of Chlamydia trachomatis eye infection is largely unsatisfactory by standard
laboratory methods. A polymerase chain reaction/enzyme immunoassay (PCR-EIA) that had …
laboratory methods. A polymerase chain reaction/enzyme immunoassay (PCR-EIA) that had …
Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us?
HR Wright, HR Taylor - The Lancet infectious diseases, 2005 - thelancet.com
Worldwide, an estimated 84 million people have active trachoma and 7· 6 million people
have trachomatous trichiasis. WHO's SAFE strategy is an effective tool in the worldwide effort …
have trachomatous trichiasis. WHO's SAFE strategy is an effective tool in the worldwide effort …
[PDF][PDF] Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal
SO Holm, HC Jha, RC Bhatta… - Bulletin of the World …, 2001 - SciELO Public Health
OBJECTIVE: The study compares the effectiveness of two strategies for distributing
azithromycin in an area with mild-to-moderate active trachoma in Nepal. METHODS: The …
azithromycin in an area with mild-to-moderate active trachoma in Nepal. METHODS: The …
[PDF][PDF] Blinding trachoma: prevention with the safe strategy
SK West - American Journal of Tropical Medicine and Hygiene, 2003 - Citeseer
Trachoma, the second leading cause of blindness worldwide, differentially affects the
poorest communities, which may have the least access to resources. With the establishment …
poorest communities, which may have the least access to resources. With the establishment …
[PDF][PDF] Trachoma: the forgotten cause of blindness
B Muñoz, S West - Epidemiologic reviews, 1997 - Citeseer
Trachoma, the second leading cause of blindness world wide, continues to be
hyperendemic in many areas of Africa, Asia, and the Middle East. Caused by an ocular …
hyperendemic in many areas of Africa, Asia, and the Middle East. Caused by an ocular …